The first edition of the Botton-Champalimaud International Pancreatic Conference, hosted at the prestigious Botton-Champalimaud Pancreatic Cancer Centre, was a landmark event in 2024, bringing together leading experts, researchers, and healthcare professionals from around the world to discuss the latest advancements in pancreatic cancer diagnosis, treatment, and care.

The Lucerne Consortium, a multidisciplinary group of European cancer societies and researchers that creates guidelines for early breast cancer care, published, in the December issue of the journal The Lancet Oncology, the conclusions of its Lucerne Toolbox 3 initiative, which pave the way to better treatment for patients in early stages of breast cancer.

The Lucerne consortium has already presented consensus recommendations for locoregional therapy after primary systemic therapy and for axillary management in early breast cancer. Now comes the turn of digital tools and AI.

With more than three decades of pioneering work in breast cancer prevention, Dr Andrea De Censi, has joined the Champalimaud Foundation as the new Director of the Breast Unit. An internationally recognised medical oncologist and a leader in chemoprevention, Dr De Censi brings a vision that integrates prevention, clinical care and translational research in a patient-centred model.